MARKET

KZIA

KZIA

Kazia
NASDAQ

Real-time Quotes | Nasdaq Last Sale

2.650
-0.250
-8.62%
Closed 16:00 04/01 EDT
OPEN
2.720
PREV CLOSE
2.900
HIGH
2.800
LOW
2.600
VOLUME
39.75K
TURNOVER
--
52 WEEK HIGH
9.74
52 WEEK LOW
2.240
MARKET CAP
15.91M
P/E (TTM)
-2.0574
1D
5D
1M
3M
1Y
5Y

EPS

KZIA News

More
  • Is Kazia Therapeutics Limited's (ASX:KZA) CEO Paid At A Competitive Rate?
  • Simply Wall St. · 02/24 21:34
  • Edison issues ADR update on Kazia Therapeutics (KZIA)
  • ACCESSWIRE · 01/13 12:55
  • SBGL, OLLI among premarket gainers
  • Seeking Alpha - Article · 12/11/2019 14:11
  • Kazia Initiates Preparatory Activities to Bring GDC-0084 into GBM AGILE, an International Phase II / III Study in Glioblastoma
  • PR Newswire · 12/11/2019 00:41

Industry

Biotechnology & Medical Research
-4.51%
Pharmaceuticals & Medical Research
-2.97%

Hot Stocks

Symbol
Price
%Change

About KZIA

Kazia Therapeutics Limited, formerly Novogen Limited, is an oncology biotechnology company, which is focused on developing cancer treatments. The Company is primarily engaged in pharmaceutical research and development. It has two drug technology platforms (the Superbenzopyran (SBP) technology and Anti-tropomyosin (ATM)) yielding various drug candidates across a range of oncology indications. The Company's product candidates include Cantrixil (TRX-E-002-1), Anisina (ATM-3507) and Trilexium (TRX-E-009-1). The Company's target indication for Cantrixil is ovarian cancer, and Diffuse Intrinsic Pontine Glioma (DIPG) for Trilexium. The initial target pediatric indication for Anisina is neuroblastoma. Cantrixil is the lead development candidate arising from its SBP technology. Anisina is an approach to chemotherapy that targets the cancer cells' actin cytoskeleton. Trilexium (TRX-E-009-1) is its second lead SBP drug candidate.
More

Webull offers kinds of Kazia Therapeutics Ltd (ADR) stock information, including NASDAQ:KZIA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, KZIA stock news, and many more online research tools to help you make informed decisions.